Reconnaître les signes de gravité systémique d’une infection ostéoarticulaire

McNally, 2021, The EBJIS definition of periprosthetic joint infection, Bone Joint J, 103, 18, 10.1302/0301-620X.103B1.BJJ-2020-1381.R1 2007, Prise en charge initiale des états septiques graves de l’adulte et de, l’enfant, Réanimation, 16, S1 Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287 Muller, 2005, Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus, Clin Infect Dis, 41, 281, 10.1086/431587 Grammatico-Guillon, 2012, Bone and joint infections in hospitalized patients in France, 2008: clinical and economic outcomes, J Hosp Infect, 82, 40, 10.1016/j.jhin.2012.04.025 Bernard, 2015, Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial, Lancet, 385, 875, 10.1016/S0140-6736(14)61233-2 Bernard, 2021, Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection, J Med, 384, 1991 McHugh, 2020, Scottish microbiology and virology network smvn molecular diagnostics evaluation group null. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management, J Med Microbiol, 69, 552, 10.1099/jmm.0.001171 Brotherton, 2020, The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteraemia utilizing the electronic health record, J Antimicrob Chemother, 75, 1054, 10.1093/jac/dkz518 Bearman, 2005, Bacteremias: a leading cause of death, Arch Med Res, 36, 646, 10.1016/j.arcmed.2005.02.005 Pedersen, 2003, Source of infection and other factors associated with case fatality in community-acquired bacteremia--a Danish population-based cohort study from 1992 to 1997, Clin Microbiol Infect, 9, 793, 10.1046/j.1469-0691.2003.00599.x Roger, 2014, The impact of bacteremia on the outcome of bone infections, Med Mal Infect, 44, 380, 10.1016/j.medmal.2014.07.013 Lee, 2014, Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study, J Antimicrob Chemother, 69, 1966, 10.1093/jac/dku076 Yu, 2008, Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China, Clin Microbiol Infect, 14, 381, 10.1111/j.1469-0691.2007.01927.x Monecke, 2007, High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus, Clin Microbiol Infect, 13, 1157, 10.1111/j.1469-0691.2007.01833.x Skiest, 2007, Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients, J Infect, 54, 427, 10.1016/j.jinf.2006.09.012 Yamasaki, 2005, The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection, Clin Infect Dis, 40, 381, 10.1086/427290 Gillet, 2002, Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients, Lancet, 359, 753, 10.1016/S0140-6736(02)07877-7 Bocchini, 2006, Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children, Pediatrics, 117, 433, 10.1542/peds.2005-0566 Martínez-Aguilar, 2004, Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children, Pediatr Infect Dis J, 23, 701, 10.1097/01.inf.0000133044.79130.2a Dohin, 2007, Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus, Pediatr Infect Dis J, 26, 1042, 10.1097/INF.0b013e318133a85e Löffler, 2010, Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils, PLoS Pathog, 6, e1000715, 10.1371/journal.ppat.1000715 Gillet, 2011, Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases, Int J Antimicrob Agents, 38, 457, 10.1016/j.ijantimicag.2011.05.003 Gillet, 2007, Osteoarticular infections with staphylococcus aureus secreting Panton-Valentine leucocidin, Arch Pediatr, 14, S102, 10.1016/S0929-693X(07)80043-1 Prothèse de hanche ou de genou : diagnostic et prise en charge de l’infection dans le mois suivant l’implantation [Internet]. Haute Autorité de Santé. [cité 27 oct 2021]. Disponible sur: https://www.has-sante.fr/jcms/c_1228574/fr/prothese-de-hanche-ou-de-genou-diagnostic-et-prise-en-charge-de-l-infection-dans-le-mois-suivant-l-implantation.